SCHEMBL6868422

SCHEMBL6868422

CCOC(=O)CC(CC)C(=O)OCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.48
GAA P10253 1/20 0.48
SI P14410 1/20 0.48
MGAM2 Q2M2H8 1/20 0.48
ALDH1A1 P00352 6/20 0.44
ALOX15 P16050 3/20 0.44
CYP3A4 P08684 2/20 0.44
TSHR P16473 2/20 0.44
TRPA1 O75762 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
HSD17B10 Q99714 2/20 0.43
CHRM1 P11229 1/20 0.43
ADORA1 P30542 1/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
CYP2D6 P10635 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP1A2 P05177 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9203447 1.00 MGAM (0.48) MGAMGAASIMGAM2ALDH1A1
SCHEMBL8719366 0.91 MGAM (0.52) MGAMGAASIMGAM2ALDH1A1
SCHEMBL27815261 0.87 MGAM (0.44) MGAMGAASIMGAM2ALDH1A1
SCHEMBL17969530 0.87 CA1 (0.52) MGAMGAASIMGAM2ALDH1A1
SCHEMBL27962264 0.86 MGAM (0.40) MGAMGAASIMGAM2ALDH1A1
SCHEMBL26914639 0.86 MGAM (0.40) MGAMGAASIMGAM2ALDH1A1
SCHEMBL27555147 0.86 RECQL (0.42) MGAMGAASIMGAM2ALDH1A1
SCHEMBL28279569 0.85 GAA (0.43) MGAMGAASIMGAM2ALDH1A1
SCHEMBL2856536 0.85 GAA (0.39) MGAMGAASIMGAM2ALDH1A1
SCHEMBL13650223 0.85 MEN1 (0.37) MGAMGAASIMGAM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114129483-B Essence containing rambutan pericarp polyphenol and milk protein and preparation method thereof 杭州配方师科技有限公司 2024-02-23 CN claimed
CN-114129483-A Essence containing rambutan peel polyphenol and milk protein and preparation method thereof 杭州配方师科技有限公司 2022-03-04 CN claimed
CN-114042008-A Essence containing cyclopeptide fatty acid compound and preparation method thereof 杭州配方师科技有限公司 2022-02-15 CN claimed
EP-0301852-B1 PROCESS FOR THE PRODUCTION OF GAMMA-BUTYROLACTONE DAVY McKEE (LONDON) LIMITED (GB) 1992-07-15 EP claimed
US-4945173-A DISTILLATION IN PRESENCE OF DIETHYL ETHOXYSUCCINATE DAVY MCKEE (LONDON) LIMITED (GB) 1990-07-31 US claimed
EP-0301852-A2 Process for the production of gamma-butyrolactone DAVY McKEE (LONDON) LIMITED (GB) 1989-02-01 EP claimed
JP-1042478-A None JP disclosed
US-20250162967-A1 PROCESS FOR PRODUCING A REFINED 1,4-BUTANEDIOL STREAM JOHNSON MATTHEY DAVY TECHNOLOGIES LIMITED (GB) 2025-05-22 US disclosed
CN-119569699-A Synthesis process of 2- (3-chloro-2-pyridyl) -5-oxo-3-pyrazolidinecarboxylic acid ethyl ester 河北帝安农生物科技有限公司 2025-03-07 CN disclosed
EP-4490137-A1 PROCESS FOR PRODUCING A REFINED 1,4-BUTANEDIOL STREAM Johnson Matthey Davy Technologies Limited (GB) 2025-01-15 EP disclosed
CN-118696022-A Method for producing a purified 1, 4-butanediol stream 庄信万丰戴维科技有限公司 2024-09-24 CN disclosed
CN-114129483-B Essence containing rambutan pericarp polyphenol and milk protein and preparation method thereof 杭州配方师科技有限公司 2024-02-23 CN disclosed
WO-2023170409-A1 PROCESS FOR PRODUCING A REFINED 1,4-BUTANEDIOL STREAM JOHNSON MATTHEY DAVY TECHNOLOGIES LIMITED (GB) 2023-09-14 WO disclosed
EP-0301853-A1 Catalyst DAVY McKEE (LONDON) LIMITED (GB) 1989-02-01 EP disclosed
EP-0301852-A2 Process for the production of gamma-butyrolactone DAVY McKEE (LONDON) LIMITED (GB) 1989-02-01 EP disclosed
EP-0301852-A2 Process for the production of gamma-butyrolactone DAVY McKEE (LONDON) LIMITED (GB) 1989-02-01 EP disclosed
US-4767869-A Process for the production of gamma-butyrolactone DAVY MCKEE LIMITED (GB) 1988-08-30 US disclosed
EP-0277168-A1 PROCESS FOR THE CO-PRODUCTION OF BUTANE-1,4-DIOL AND $i(GAMMA)-BUTYROLACTONE DAVY McKEE (LONDON) LIMITED (GB) 1988-08-10 EP disclosed
WO-1988000937-A1 PROCESS FOR THE CO-PRODUCTION OF BUTANE-1,4-DIOL AND GAMMA-BUTYROLACTONE DAVY MCKEE (LONDON) LIMITED (GB) 1988-02-11 WO disclosed
EP-0255400-A1 Process for the production of butyrolactone DAVY McKEE (LONDON) LIMITED (GB) 1988-02-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250162967-A1 PROCESS FOR PRODUCING A REFINED 1,4-BUTANEDIOL STREAM HSD17B7, ADH1C, SORD MGAM 837/4885GAA 3275/4885SI 495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.